Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Type 1 autoimmune pancreatitis is a form of autoimmune pancreatitis seen in elderly males (>60 years) and presenting with abdominal pain, steatorrhea, obstructive jaundice and other organ (bile duct, kidneys and retroperitoneum) involvement. It is thought to be due to an immunoglobulin G4 (IgG4)-associated systemic disease.
Biomarker and diagnostic research for autoimmune pancreatitis type 1 has been reported in the published literature.
Estimated prevalence: Unknown (Unknown prevalence).
1 clinical trial registered.
24 publications have been identified in PubMed for autoimmune pancreatitis type 1. Research spans Case Report / Case Series (33%), Review / Meta-Analysis (25%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 8 | 33% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 11:12 AM UTC
European rare disease database
Genetic and Rare Diseases Info Center
6 |
25% |
Clinical study results | 3 | 13% |
Other research | 2 | 8% |
Testing and diagnosis research | 2 | 8% |
Disease patterns and progression | 2 | 8% |
Laboratory research | 1 | 4% |
Falk L (2026). [PMID: 41961744](https://pubmed.ncbi.nlm.nih.gov/41961744/). *Digestion*. [Diagnostic / Biomarker]
Qiao J (2026). [PMID: 41560072](https://pubmed.ncbi.nlm.nih.gov/41560072/). *Medicine (Baltimore)*. [Case Report / Case Series]
Basyal B (2026). [PMID: 32809604](https://pubmed.ncbi.nlm.nih.gov/32809604/). *Unknown Journal*. [Review / Meta-Analysis]
Tian X (2026). [PMID: 41735850](https://pubmed.ncbi.nlm.nih.gov/41735850/). *BMC Gastroenterol*. [Clinical Trial Publication]
Ito T (2025). [PMID: 40019478](https://pubmed.ncbi.nlm.nih.gov/40019478/). *Pancreas*. [Clinical Trial Publication]
Kler A (2025). [PMID: 40791301](https://pubmed.ncbi.nlm.nih.gov/40791301/). *ACG Case Rep J*. [Case Report / Case Series]
Mills KC (2025). [PMID: 39880531](https://pubmed.ncbi.nlm.nih.gov/39880531/). *Gastroenterol Clin North Am*. [Review / Meta-Analysis]
Liu J (2025). [PMID: 41531635](https://pubmed.ncbi.nlm.nih.gov/41531635/). *Cureus*. [Case Report / Case Series]
Wu S (2025). [PMID: 40599784](https://pubmed.ncbi.nlm.nih.gov/40599784/). *Front Immunol*. [Review / Meta-Analysis]
Yonamine K (2025). [PMID: 40150887](https://pubmed.ncbi.nlm.nih.gov/40150887/). *Clin Endosc*. [Diagnostic / Biomarker]